Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity
Kevin Lin(The University of Texas MD Anderson Cancer Center), Kris C. Wood(Duke University), Timothy R. Koves(Duke University), Julia M. Lloyd-Cowden(Duke Medical Center), Chad M. McCall(Duke Medical Center), Nancie J. MacIver(University of North Carolina at Chapel Hill), Abigail Xie(Duke University), Timothy S. Pardee(Atrium Health Wake Forest Baptist), Amanda Nichols(Duke University), Ryan S. Soderquist(Duke University), David A. Rizzieri(Duke University), Deborah M. Muoio(Duke University), Jatinder K. Lamba(University of Florida), Justine C. Rutter(Duke University), Lucie Ahn(Case Western Reserve University)
Cited by 112
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
The Failing Heart Relies on Ketone Bodies as a Fuel
|Circulation|2016|706
Changes in Nutritional Status Impact Immune Cell Metabolism and Function
|Frontiers in Immunology|2018|515
Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits
|Cell Metabolism|2015|486